A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00413036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Single-Arm, Open-Label Study To Evaluate The Safety And Efficacy Of Single-Agent Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Subjects who qualify will receive oral lenalidomide daily on days 1-21 of every 28 day cycle. Treatment will continue until disease progression, or unacceptable adverse events develop
Study identification
- NCT ID
- NCT00413036
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 217 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Apr 2011 (Actual)
- Completion
- May 2011 (Actual)
- Last update posted
- Mar 1, 2017
2006 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Alabama Cancer Center, PC | Muscle Shoals | Alabama | 35661 | — |
| Mayo Clinic Scottsdale | Scottsdale | Arizona | 85259 | — |
| Lalita Pandit, MD, Inc | Fountain Valley | California | 92708 | — |
| Access Clinical Research | Rancho Mirage | California | 92270 | — |
| Kaiser Permanente Medical Group | San Diego | California | 92120 | — |
| Pasco Hernando Oncology Associates | Brooksville | Florida | 34613 | — |
| Sylvester Cancer Center/ Univeristy of Miami | Miami | Florida | 33136 | — |
| Hematology Oncology Associates of Central Brevard | Rockledge | Florida | 32955 | — |
| Palm Beach Cancer Institute | West Palm Beach | Florida | 33401 | — |
| Cancer Care Center, Inc. | New Albany | Indiana | 47150 | — |
| Ochsner Clinic Foundation | Baton Rouge | Louisiana | 70809 | — |
| Michigan Hematology and Oncology Institute | Southgate | Michigan | 48195 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| University of Nebraska | Omaha | Nebraska | 68198 | — |
| Center for Cancer and Hematologic Disease | Cherry Hill | New Jersey | 08003 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Our Lady of Mercy Cancer Center | The Bronx | New York | 10466 | — |
| HIllman Cancer Center -UPMC | Pittsburgh | Pennsylvania | 15232 | — |
| Palmetto Hematology Oncology | Spartanburg | South Carolina | 29303 | — |
| Family Cancer Center | Collierville | Tennessee | 38017 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00413036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00413036 live on ClinicalTrials.gov.